Success Metrics

Clinical Success Rate
91.2%

Based on 31 completed trials

Completion Rate
91%(31/34)
Active Trials
6(12%)
Results Posted
65%(20 trials)
Terminated
3(6%)

Phase Distribution

Ph not_applicable
4
8%
Ph phase_1
12
24%
Ph phase_4
13
27%
Ph phase_3
10
20%
Ph phase_2
7
14%

Phase Distribution

12

Early Stage

7

Mid Stage

23

Late Stage

Phase Distribution46 total trials
Phase 1Safety & dosage
12(26.1%)
Phase 2Efficacy & side effects
7(15.2%)
Phase 3Large-scale testing
10(21.7%)
Phase 4Post-market surveillance
13(28.3%)
N/ANon-phased studies
4(8.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.2%

31 of 34 finished

Non-Completion Rate

8.8%

3 ended early

Currently Active

6

trials recruiting

Total Trials

49

all time

Status Distribution
Active(7)
Completed(31)
Terminated(3)
Other(8)

Detailed Status

Completed31
unknown8
Recruiting6
Terminated3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
49
Active
6
Success Rate
91.2%
Most Advanced
Phase 4

Trials by Phase

Phase 112 (26.1%)
Phase 27 (15.2%)
Phase 310 (21.7%)
Phase 413 (28.3%)
N/A4 (8.7%)

Trials by Status

completed3163%
terminated36%
not_yet_recruiting12%
unknown816%
recruiting612%

Recent Activity

Clinical Trials (49)

Showing 20 of 49 trialsScroll for more
NCT03561584Phase 2

Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis

Completed
NCT03739853Phase 4

Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial

Completed
NCT05703425Phase 2

The Effect of Sulfasalazine on CRH Levels in Pregnant Women

Recruiting
NCT07138898Phase 2

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

Not Yet Recruiting
NCT03414502Phase 3

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

Recruiting
NCT03254589Phase 4

Methotrexate, Blood Pressure and Arterial Function in Rheumatoid Arthritis

Completed
NCT03847311Phase 2

Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients

Completed
NCT04720183Phase 1

Drug-drug Interaction Study with GLPG3970 and Sulfasalazine in Adult, Healthy Subjects

Completed
NCT04725422

CHronic Nonbacterial Osteomyelitis International Registry

Recruiting
NCT02451748Phase 4

IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA

Completed
NCT05580861Phase 1

Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment

Recruiting
NCT05664464Phase 1

Glutamate Inhibitors in Glioblastoma

Recruiting
NCT06134388Phase 3

Sulfasalazine in Patients With Metastatic Colorectal Cancer

Recruiting
NCT04205357Phase 1

Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastoma

Completed
NCT05445440Phase 1

A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine

Completed
NCT04610476Phase 3

Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis

Unknown
NCT02374021Phase 4

Treatments Against RA and Effect on FDG-PET/CT

Completed
NCT03440892

Effects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis Patients

Unknown
NCT03449758Phase 4

Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis

Completed
NCT04268394Phase 1

A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677

Completed

Drug Details

Intervention Type
DRUG
Total Trials
49